摘要 |
The subject invention provides a compound having the structure: wherein Y is O, NR<SUB>3</SUB>R<SUB>4 </SUB>or NOR<SUB>6</SUB>; R<SUB>3 </SUB>is H, alkyl, aralkyl, alkynyl, trifluoroacetyl, t-butoxycarbonyl or an acyl group; R<SUB>4 </SUB>is H, alkyl, aralkyl, or alkynyl; R<SUB>6 </SUB>is H or C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; R<SUB>1 </SUB>and R<SUB>2 </SUB>are each independently H, alkyl, aralkyl, or alkynyl; the curved line drawn from S to the center of the phenyl ring and the straight line drawn from N to the center of the ring indicate that S and N are part of a 5 membered ring which shares two carbons with the phenyl ring; and the dashed line drawn from the carbon atom on the cyclopentyl ring to Y represents a bond when Y is O or NOR<SUB>6 </SUB>and is absent when Y is NR<SUB>3</SUB>R<SUB>4</SUB>, and wherein wherein X is H or O; and R<SUB>5 </SUB>is H, alkyl, trifluoroacetyl, t-butoxycarbonyl or an acyl group, or an enantiomer, or a tautomer, or a pharmaceutically acceptable salt thereof, a process for preparing the compounds and a method of treating Parknison's disease, multiple sclerosis or depression with the compounds of the invention.
|